Global burden. Of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet. 2020;396(10258):1204–22.


Google Scholar 

BENDER R G, SIROTA S B, SWETSCHINSKI L R, et al. Global, regional, and National incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the global burden of disease study 2021 [J]. Lancet Infect Dis. 2024;24(9):974–1002.


Google Scholar 

O’BRIEN K L, BAGGETT H C, BROOKS W A, et al. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and asia: the PERCH multi-country case-control study [J]. Lancet. 2019;394(10200):757–79.


Google Scholar 

JAIN S, WILLIAMS D J, ARNOLD S R, et al. Community-acquired pneumonia requiring hospitalization among U.S. Children [J]. N Engl J Med. 2015;372(9):835–45.


Google Scholar 

LI Y, WANG X, BLAU D M, et al. Global, regional, and National disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis [J]. Lancet. 2022;399(10340):2047–64.


Google Scholar 

Bivalent Prefusion BUONSENSOD. Vaccine in pregnancy to prevent RSV illness in infants [J]. N Engl J Med. 2023;389(11):1053.


Google Scholar 

MAZUR N I, CABALLERO M T, NUNES MC. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies [J]. Lancet. 2024;404(10458):1143–56.


Google Scholar 

TURYASIIMA M, KICONCO G, EGESA W I, et al. Prevalence and outpatient clinical diagnostic approaches for common acute respiratory tract infections in children under five years of age: A Cross-Sectional study [J]. Pediatr Health Med Ther. 2024;15:49–57.


Google Scholar 

Van Meel ER, Mensink-Bout SM, Den Dekker HT, et al. Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children. Eur Respir J. 2022. https://doi.org/10.1183/13993003.02395-2021.


Google Scholar 

Age-sex differences. In the global burden of lower respiratory infections and risk factors, 1990–2019: results from the global burden of disease study 2019 [J]. Lancet Infect Dis. 2022;22(11):1626–47.


Google Scholar 

Jin W, Wang Q, Jin C, et al. Spatiotemporal distributions and regional disparities of rheumatoid arthritis in 953 global to local locations, 1980–2040, with deep learning-empowered forecasts and evaluation of interventional policies’ benefits. Ann Rheum Dis. 2025;84(7):1104–16.


Google Scholar 

Global burden and strength of evidence for. 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021 [J]. Lancet. 2024;403(10440):2162–203.


Google Scholar 

Xu H, Xiao W, Ding C, et al. Global burden of osteoarthritis among postmenopausal women in 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. BMJ Glob Health. 2025. https://doi.org/10.1136/bmjgh-2024-017198.


Google Scholar 

Jiang CY, Han K, Yang F, et al. Global, regional, and national prevalence of hearing loss from 1990 to 2019: a trend and health inequality analyses based on the Global Burden of Disease Study 2019. Ageing Res Rev. 2023;92:102124.


Google Scholar 

Wang X, Shang A, Chen H, et al. Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: findings from the Global Burden of Disease Study 2021. Drug Resist Updat. 2025;82:101265.


Google Scholar 

Yu E, Li C. Global trends and attributable risk factors in the disease burden of lower respiratory infections. Trop Med Infect Dis. 2025. https://doi.org/10.3390/tropicalmed10070180.


Google Scholar 

Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21(3):195–210.


Google Scholar 

ISLAM N, SHARP SJ, CHOWELL G, et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries [J]. BMJ. 2020;370:m2743.


Google Scholar 

SULLIVAN S G CARLSONS, CHENG A C et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020 [J]. Euro Surveill, 2020, 25(47). https://doi.org/10.2807/1560-7917.

Chuang YC, Lin KP, Wang LA, et al. The impact of the COVID-19 pandemic on respiratory syncytial virus infection: a narrative review. Infect Drug Resist. 2023;16:661–75.


Google Scholar 

Ma R, Zhang C, Zhang Y, et al. The impact of respiratory syncytial virus on asthma development and exacerbation. Ann Allergy Asthma Immunol. 2025. https://doi.org/10.1016/j.anai.2025.05.011.


Google Scholar 

Ehsan H. Antibiotic resistance in developing countries: emerging threats and policy responses. Public Health Challenges. 2025. https://doi.org/10.1002/puh2.70034.


Google Scholar 

Bakke PS. Factors affecting growth of FEV1. Monaldi Arch Chest Dis. 2003;59(2):103–7.


Google Scholar 

Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101(9):1845–63.


Google Scholar 

Alessandrini J, Smith BT, Fitzpatrick T, et al. Socioeconomic inequities in the age-specific burden of severe respiratory syncytial virus in Canada, 2016–2019. J Infect Dis. 2025;231(4):e626–37.


Google Scholar 

The unfinished agenda. Of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the global burden of disease study 2019 [J]. Lancet. 2023;402(10398):313–35.


Google Scholar 

DHERANI M, POPE D, MASCARENHAS M, et al. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis [J]. Bull World Health Organ. 2008;86(5):390–c8.


Google Scholar 

Asri AK, Pan WC, Lee HY, et al. Spatial patterns of lower respiratory tract infections and their association with fine particulate matter. Sci Rep. 2021;11(1):4866.


Google Scholar 

Whitney CG, Harper SA. Lower respiratory tract infections: prevention using vaccines. Infect Dis Clin North Am. 2004;18(4):899–917.


Google Scholar 

Ogunkola IO, Adebisi YA, Imo UF, et al. Impact of COVID-19 pandemic on antenatal healthcare services in Sub-Saharan Africa. Public Health Pract. 2021;2:100076.


Google Scholar 

Braam DH, Srinivasan S, Church L, et al. Lockdowns, lives and livelihoods: the impact of COVID-19 and public health responses to conflict affected populations – a remote qualitative study in Baidoa and Mogadishu, Somalia. Confl Health. 2021;15(1):47.


Google Scholar 

Mitchell HK, Reddy A, Perry MA, et al. Racial, ethnic, and socioeconomic disparities in paediatric critical care in the USA. The Lancet Child & Adolescent Health. 2021;5(10):739–50.


Google Scholar 

Wu Y, Song P, Lin S, et al. Global burden of respiratory diseases attributable to ambient particulate matter pollution: findings from the Global Burden of Disease Study 2019. Front Public Health. 2021;9:740800.


Google Scholar 

Holloway KA, Henry D. Identifying the most effective policies for minimising inappropriate use of antibiotics: a replicability study using three WHO datasets. Health Policy. 2025;155:105269.


Google Scholar 

Rostad CA. Respiratory syncytial virus: spectrum of clinical manifestations and complications in children. Pediatr Ann. 2019;48(9):e349–53.


Google Scholar 

Langley JM, Leblanc JC, Wang EE, et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study. Pediatrics. 1997;100(6):943–6.


Google Scholar 

Yu X, Wang H, Ma S, et al. Estimating the global and regional burden of lower respiratory infections attributable to leading pathogens and the protective effectiveness of immunization programs. Int J Infect Dis. 2024;149:107268.


Google Scholar